Advertisement
News
Advertisement

Knome's genome sequencing platform boosted by $5M funding

Tue, 08/02/2011 - 9:45am
Mass High Tech: The Journal of New England Technology

Cambridge-based genome analysis platform company Knome Inc. has pulled in $5 million of an expected $20 million equity funding round, federal documents show.

The filing with the U.S. Securities and Exchange Commission indicated participation from one investor, though the backer was not identified specifically. Knome’s previous backers include French diagnostics firm bioMerieux, which put $5 million into an equity stake in the Cambridge company in April 2010.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading